Mechanism of toxicity of pesticides acting at complex I: Relevance to environmental etiologies of Parkinson's disease

Journal of Neurochemistry

Volumn 100, Issue 6, 2007, Pages 1469-1479

  Sherer, Todd B ^a,f   Richardson, Jason R ^a,b,g   Testa, Claudia M ^a   Seo, Byoung Boo ^c   Panov, Alexander V ^a   Yagi, Takao ^c   Matsuno Yagi, Akemi ^c   Miller, Gary W ^a,b   Greenamyre, J Timothy ^a,d,e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^g RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Complex I; Mitochondria; NADH dehydrogenase; Oxidative stress; Parkinson's disease; Pesticide

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; DIHYDROROTENONE; FENAZAQUIN; FENPYROXIMATE; PESTICIDE; PYRIDABEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; ROTENONE; TEBUNFENPYRAD; TRITIUM; UBIDECARENONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MESENCEPHALON; MITOCHONDRIAL RESPIRATION; NEUROBLASTOMA; NONHUMAN; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SACCHAROMYCES CEREVISIAE;

ADENOSINE TRIPHOSPHATE; ALPHA-TOCOPHEROL; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRON TRANSPORT COMPLEX I; HUMANS; MALE; MESENCEPHALON; MITOCHONDRIA; NADH DEHYDROGENASE; NEUROBLASTOMA; PESTICIDES; PROTEIN CARBONYLATION; RATS; RATS, INBRED LEW; ROTENONE; SACCHAROMYCES CEREVISIAE PROTEINS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; SACCHAROMYCES CEREVISIAE;

EID: 33847694006     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04333.x     Document Type: Article

References (47)

1. Ascherio A., Chen H., Weisskopf M. G., O'Reilly E., McCullough M. L., Calle E. E., Schwarzschild M. A. and Thun M. J. (2006) Pesticide exposure and risk for Parkinson's disease. Ann. Neurol. 60, 197-203.
2. Bai Y., Hajek P., Chomyn A., Chan E., Seo B. B., Matsuno-Yagi A., Yagi T. and Attardi G. (2001) Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene. J. Biol. Chem. 276, 38 808-38 813.
3. Barrientos A. and Moraes C. T. (1999) Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274, 16 188-16 197.
4. Beal M. F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
5. Beal M. F. (2002). Oxidatively modified proteins in aging and disease. Free Radical Biol. Med. 32, 797-803.
6. Beal M. F. (2003) Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann. NY Acad. Sci. 991, 120-131.
7. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
8. Betarbet R., Sherer T. B. and Greenamyre J. T. (2002) Animal models of Parkinson's disease. Bioessays 24, 308-318.
9. Cassarino D. S., Fall C. P., Swerdlow R. H., Smith T. S., Halvorsen E. M., Miller S. W., Parks J. P., Parker W. D. Jr and Bennett J. P. Jr (1997) Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta 1362, 77-86.
10. Degli Esposti M. (1998) Inhibitors of NADH-ubiquinone reductase: an overview. Biochim. Biophys. Acta 1364, 222-235.
11. Gorell J. M., Johnson C. C., Rybicki B. A., Peterson E. L. and Richardson R. J. (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 50, 1346-1350.
12. Greenamyre J. T., Higgins D. S. and Eller R. V. (1992) Quantitative autoradiography of diohydrorotenone binding to complex I of the electron transport chain. J. Neurochem. 59, 746-749.
13. Greenamyre J. T., Sherer T. B., Betarbet R. and Panov A. V. (2001) Complex I and Parkinson's disease. IUBMB Life 52, 135-141.
14. Hastings T. G. and Zigmond M. J. (1997) Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. J. Neural. Transm. Suppl. 49, 103-110.
15. Higgins D. S. and Greenamyre J. T. (1996) [3H] dihydrorotenone binding to NADH:ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. J. Neurosci. 16, 3807-3816.
16. Hoppel C., DiMarco J. and Tandler B. (1979) Riboflavin and rat hepatic cell structure and function. Mitochondrial oxidative metabolism in deficiency states. J. Biol. Chem. 254, 4164-4170.
17. Jenner P. (2003) Oxidative stress in Parkinson's disease. Ann. Neurol. 53(Suppl. 3), S26-36; discussion S36-28.
18. Jha N., Jurma O., Lalli G., Liu Y., Pettus E. H., Greenamyre J. T., Liu R.M., Forman H. J. and Andersen J. K. (2000) Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 275, 26 096-26 101.
19. Kushnareva Y., Murphy A. N. and Andreyev A. (2002) Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem. J. 368, 545-553.
20. Langston J. W., Ballard P., Tetrud J. W. and Irwin I. (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
21. Le Couteur D. G., McLean A. J., Taylor M. C., Woodham B. L. and Board P. G. (1999) Pesticides and Parkinson's disease. Biomed. Pharmacother. 53, 122-130.
22. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J. A. and Robinson J. P. (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278, 8516-8525.
23. Lummen P. (1998) Complex I inhibitors as insecticides and acaricides. Biochim. Biophys. Acta. 1364, 287-296.
24. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T. and Kagawa Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
25. Nicklas W. J., Vyas I. and Heikkila R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36, 2503-2508.
26. Okun J. G., Lummen P. and Brandt U. (1999) Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase). J. Biol. Chem. 274, 2625-2630.
27. Olanow C. W. and Tatton W. G. (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144.
28. Panov A. V. and Scaduto R. C. Jr (1996) Substrate specific effects of calcium on metabolism of rat heart mitochondria. Am. J. Physiol. 270, H1398-1406.
29. Panov A. V., Andreeva .L and Greenamyre J. T. (2004) Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. Arch Biochem Biophys 424, 44-52.
30. Parker W. D. Jr, Boyson S. J. and Parks J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26, 719-723.
31. Priyadarshi A., Khuder S. A., Schaub E. A. and Shrivastava S. (2000) A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 21, 435-440.
32. Priyadarshi A., Khuder S. A., Schaub E. A. and Priyadarshi S. S. (2001) Environmental risk factors and Parkinson's disease: a metaanalysis. Environ. Res. 86, 122-127.
33. Ravina B. M., Fagan S. C., Hart R. G., Hovinga C. A., Murphy D. D., Dawson T. M. and Marler J. R. (2003) Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment. Neurology 60, 1234-1240.
34. Richardson J. R., Caudle W. M., Guillot T. S. et al. (2006) Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-tetrahydropyridine (MPTP). Toxicol. Sci. Epub Oct. 12.
35. Richardson J. R., Quan Y., Sherer T. B., Greenamyre J. T. and Miller G. W. (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol. Sci. 88, 193-201.
36. Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B. and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
37. Schuler F. and Casida J. E. (2001) The insecticide target in the PSST subunit of complex I. Pest. Manag. Sci. 57, 932-940.
38. Semchuk K. M., Love E. J. and Lee R. G. (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42, 1328-1335.
39. Seo B. B., Wang J., Flotte T. R., Yagi T. and Matsuno-Yagi A. (2000) Use of the NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae as a possible cure for complex I defects in human cells. J. Biol. Chem. 275, 37 774-37 778.
40. Seo B. B., Nakamaru-Ogiso E., Flotte T. R., Yagi T. and Matsuno-Yagi A. (2002) A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. Mol. Ther. 6, 336-341.
41. Sherer T. B., Betarbet R. and Greenamyre J. T. (2002a) Environment, mitochondria, and Parkinson's disease. Neuroscientist 8, 192-197.
42. Sherer T. B., Betarbet R., Stout A. K., Lund S., Baptista M., Panov A. V., Cookson M. R. and Greenamyre J. T. (2002b) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22, 7006-7015.
43. Sherer T. B., Betarbet R., Testa C. M., Seo B. B., Richardson J. R., Kim J. H., Miller G. W., Yagi T., Matsuno-Yagi A. and Greenamyre J. T. (2003a) Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23, 10 756-10 764.
44. Sherer T. B., Kim J. H., Betarbet R. and Greenamyre J. T. (2003b) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179, 9-16.
45. Sipos I., Tretter L. and Adam-Vizi V. (2003) The production of reactive oxygen species in intact isolated nerve terminals is independent of the mitochondrial membrane potential. Neurochem. Res. 28, 1575-1581.
46. Stoppini L., Buchs P. A. and Muller D. (1991) A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173-182.
47. Testa C. M., Sherer T. B. and Greenamyre J. T. (2005) Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Mol. Brain Res. 134, 109-118.